Published in JAMA on August 04, 1989
The process of leukemogenesis. Environ Health Perspect (1996) 0.93
Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups. Br J Cancer (2002) 0.86
Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia. Br J Cancer (2002) 0.76
Acute leukemia in adult Hispanic Americans: a large-population study. Blood Cancer J (2016) 0.75
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood (1996) 13.35
Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science (1987) 4.02
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol (2000) 3.50
Controlled trial of aspirin in cerebral ischemia. Stroke (1977) 3.48
Superoxide dismutase as a target for the selective killing of cancer cells. Nature (2000) 3.44
Rituximab dose-escalation trial in chronic lymphocytic leukemia. J Clin Oncol (2001) 3.38
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol (1990) 3.19
Neurobehavioral outcome following minor head injury: a three-center study. J Neurosurg (1987) 2.92
Headache in the emergency department. Headache (2001) 2.87
Excess and deficit lung cancer mortality in three ethnic groups in Texas. Cancer (1976) 2.64
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia (2003) 2.60
Community-wide coronary heart disease mortality in Mexican Americans equals or exceeds that in non-Hispanic whites: the Corpus Christi Heart Project. Am J Med (2001) 2.47
Evaluation of performance of selected devices for measuring blood pressure. Am J Cardiol (1973) 2.45
Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res (2001) 2.41
Worst headache and subarachnoid hemorrhage: prospective, modern computed tomography and spinal fluid analysis. Ann Emerg Med (1998) 2.10
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol (1988) 2.06
[Pattern of the distribution of total cholesterol and cHDL cholesterol Spanish children and adolescents: RICARDIN Study]. Med Clin (Barc) (2000) 1.98
Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res (1976) 1.97
Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy. Cancer (1999) 1.90
High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg (1988) 1.87
Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N Engl J Med (1986) 1.86
Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities. Haematologica (2000) 1.81
An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project. Int J Epidemiol (1996) 1.80
Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia (2003) 1.76
Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies. Bioinformatics (2004) 1.72
DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine. Clin Cancer Res (2001) 1.71
Greater case-fatality after myocardial infarction among Mexican Americans and women than among non-Hispanic whites and men. The Corpus Christi Heart Project. Am J Epidemiol (1994) 1.62
Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer (1988) 1.62
A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature (1987) 1.61
Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology (1998) 1.56
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med (1987) 1.55
Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol (1986) 1.54
Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfa. Arch Otolaryngol Head Neck Surg (1992) 1.52
Low birth weight and blood pressure at age 7-11 years in a biracial sample. Am J Epidemiol (1997) 1.51
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol (1999) 1.51
HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood (1988) 1.51
Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics. Bone Marrow Transplant (2004) 1.50
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia. Cancer Res (1990) 1.50
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration. Leukemia (2012) 1.49
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis. Blood (1992) 1.48
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.48
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma (1993) 1.45
Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood (2001) 1.43
Factors related to length of complete remission in adult acute leukemia. Cancer (1980) 1.42
A population-based assessment of the use and effectiveness of thrombolytic therapy. The Corpus Christi Heart Project. Ann Epidemiol (1995) 1.42
Rise of blood pressure with age. New evidence of population differences. Hypertension (1994) 1.42
Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. Am J Med (1992) 1.41
A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood (1985) 1.39
Serum lactate dehydrogenase-3 isoenzyme in chronic granulocytic leukemia. Am J Clin Pathol (1991) 1.39
Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota. Lancet (1975) 1.38
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. J Clin Oncol (1993) 1.38
Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia (1996) 1.36
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine (Baltimore) (1979) 1.36
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. J Clin Oncol (2005) 1.32
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med (1987) 1.30
Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med (1991) 1.28
Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am J Obstet Gynecol (1984) 1.27
Comparison of stroke hospitalization rates among Mexican-Americans and non-Hispanic whites. Neurology (2000) 1.24
Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients. Arch Intern Med (1984) 1.24
Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc (2000) 1.23
Malignant gingival and skin "infiltrates" in adult leukemia. Oral Surg Oral Med Oral Pathol (1983) 1.23
Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia. Leukemia (1989) 1.22
Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism. Leukemia (2008) 1.21
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Arch Intern Med (1992) 1.21
Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells. Blood (1997) 1.20
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. Leukemia (2004) 1.20
Greater incidence of hospitalized myocardial infarction among Mexican Americans than non-Hispanic whites. The Corpus Christi Heart Project, 1988-1992. Circulation (1997) 1.19
Controlled trial of aspirin in cerebral ischemia. Part II: surgical group. Stroke (1978) 1.19
Richter's syndrome: a report on 39 patients. J Clin Oncol (1993) 1.19
Brain tumor masquerading as stroke. J Neurooncol (1999) 1.19
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells. Leukemia (2005) 1.18
Clinical investigation of human alpha interferon in chronic myelogenous leukemia. Blood (1987) 1.17
A meta-analysis of trials evaluating patient education and counseling for three groups of preventive health behaviors. Patient Educ Couns (1997) 1.17
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol (1990) 1.16
Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood (1987) 1.15
Mild hypertension: the question of treatment. Annu Rev Public Health (1986) 1.15
Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology (2001) 1.15
Alcohol consumption and nearly lethal suicide attempts. Suicide Life Threat Behav (2001) 1.14
Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol Cell Biol (1992) 1.14
Recruitment and enrollment for Project HeartBeat! Achieving the goals of minority inclusion. Ethn Dis (1996) 1.14
Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL). Leukemia (2002) 1.13
Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia. Medicine (Baltimore) (1978) 1.12
Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response. Br J Clin Pharmacol (2007) 1.12
The evolution of the retinotectal map during development in Xenopus. Proc R Soc Lond B Biol Sci (1974) 1.12
Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic white children: the Corpus Christi Child Heart Study. Circulation (1997) 1.12
The visual system and "neuronal specificity". Nature (1972) 1.11
Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. Oncogene (1996) 1.11
Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer (1977) 1.10
Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia. Leukemia (2005) 1.10
The characteristics and outcome of patients with late relapse acute myelogenous leukemia. J Clin Oncol (1988) 1.10
General implications of chromosomal alterations in human leukemia. Hum Pathol (1974) 1.09
Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Engl J Med (1980) 1.09
The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics. Clin Cancer Res (1999) 1.08
Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy. Cancer Res (1987) 1.08
Women and Mexican Americans receive fewer cardiovascular drugs following myocardial infarction than men and non-Hispanic whites: the Corpus Christi Heart Project, 1988-1990. J Clin Epidemiol (1996) 1.07